You are here: Industry Insights > Cell Therapy

News List

Century Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares firstwordpharma
June 23, 2021
Century Therapeutics (NASDAQ: IPSC) today announced the closing of its initial public offering of 12,132,500 shares of its common stock at a public offering price of $20.00 per share
More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities prnewswire
June 23, 2021
We are in a new era of medicine where groundbreaking biopharmaceutical research and development is transforming medicine, but these innovations are meaningless if they don't reach patients, including those in underserved communities.
Dendreon Pharmaceuticals Establishes Contract Manufacturing Division contractpharma
June 16, 2021
Now offers end-to-end manufacturing of complex cell therapies and patient logistics for partner programs.
Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction firstwordpharma
June 15, 2021
Avalon GloboCare Corp. (NASDAQ: AVCO) , a clinical-stage global developer of cell-based technologies and therapeutics, today announced that it has entered into a definitive agreement to acquire Hebei Senlang Biotechnology Co. Ltd.
Strengthens Investment in Licensed mRNA Technology Platform with $20M Financing firstwordpharma
May 25, 2021
Brooklyn today announced it has completed a $20M financing to progress the development of the mRNA gene editing and cell therapies technology recently licensed from Factor Biosciences and Novellus Therapeutics.
Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy Manufacturing prnasia
May 08, 2021
Cellares Corporation, a life sciences technology company that automates cell therapy manufacturing, announced it has secured $82 million in a Series B round, bringing total funding to date to $100 million.
Cellares Expands Cell Therapy Manufacturing Capabilities contractpharma
May 06, 2021
Cellares Corporation, a life sciences technology company that automates cell therapy manufacturing, has secured $82 million in a Series B round, bringing total funding to date to $100 million.
Bristol Myers Squibb Invests in Cell Therapy Ops contractpharma
April 28, 2021
Bristol Myers Squibb has selected Leiden, Netherlands to house a new cell therapy manufacturing site in Europe, leveraging the growing life sciences region near Amsterdam and convenient access to transportation for shipping patient cells.
BMS to invest in new cell therapy manufacturing site in Europe pharmatimes
April 26, 2021
Bristol Myers Squibb (BMS) is planning to invest in a new cell therapy manufacturing site based in Leiden in the Netherlands.
BMS Expands Cell Therapy Manufacturing Capabilities contractpharma
March 02, 2021
New state-of-the-art cell therapy manufacturing facility under construction to expand global footprint.

Previous page 1 2 3 4 5 6 7 8 Next page